Certain Lots Of Taro-zoledronic Acid Injection Drug, Used For Osteoporosis And Paget's Disease, Recalled Due To Potential Presence Of Particulate Matter

Taro-Zoledronic Acid Injection Recall Certain lots of Taro-Zoledronic acid injection, a medication used to treat osteoporosis and Paget's disease, are being recalled across Canada because they may contain particulate matter (small solid particles). The affected lots are distributed nationwide. This recall applies to people who have received or may receive this medication during the affected period.

Category

consumer product recall

Country

Canada

Agency

HC-PRODUCTS

Recall date

2020-03-31

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-PRODUCTS

Recall details on Nibble Recalls: https://trynibble.app/recalls/c719b618-dd48-443e-91dc-f8e383e2c93b